LifeWatch AG

EANS-Adhoc: LifeWatch AG/ AETNA contracts with LifeWatch nationally for NiteWatch Home Sleep Testing

@@start.t1@@--------------------------------------------------------------------------------   ad-hoc disclosure transmitted by euro adhoc with the aim of a Europe-wide   distribution. The issuer is solely responsible for the content of this   announcement. --------------------------------------------------------------------------------@@end@@

22.09.2010

Neuhausen am Rheinfall / Switzerland - LifeWatch AG (SIX Swiss Exchange:  LIFE), the leading provider of wireless telemedicine, announced today  that  Aetna  now has a national contract with LifeWatch to provide access to the  NiteWatch  Home Sleep Test (HST) service for their members effective September 15, 2010.

A large percentage of patients with suspected Obstructive Sleep Apnea (OSA)  are reluctant to go to a sleep lab to be tested.  Since  38   million  Americans  are affected by OSA1, millions of patients remain undiagnosed and at risk  for  more serious complications from OSA like stroke and heart disease. NiteWatch  HST  is clinically equivalent to sleep lab testing for diagnosing OSA and  is  conducted in the privacy of the patient´s home making it a less  intimidating   alternative for many patients and concerned loved ones.

LifeWatch serves physicians by  integrating  electronic  medical   records  (EMR) with remote telemedicine services to support  more   cost  effective  and  timely services while providing clinically relevant decisional  information.  NiteWatch HST now expands patient care options to all  physicians.  This  is  yet  another example of how LifeWatch is scaling and aggregating a variety  of  solutions  to address growing healthcare needs and industry challenges.

"The addition of NiteWatch service to  the  Aetna  national  provider agreement represents an important  step  in  our  goal  to  provide   the  highest  quality diagnostic services at an economical delivery cost," said Brent  Cohen,  CEO  of LifeWatch. "Changing the way healthcare is delivered and serviced  is  essential to effecting change and allowing high quality clinically  superior  services  to be affordable and available to  all.  Working  with  progressive   thinkers  like Aetna will allow LifeWatch to make a  contribution  by making  affordable  home sleep testing services broadly available through all physicians."

About LifeWatch AG LifeWatch AG, headquartered in Neuhausen am Rheinfall and listed  on  SIX  Swiss Exchange (LIFE), Switzerland, is the leading healthcare technology and  solution company, specializing in  advanced  telemedicine  systems  and  wireless  remote patient monitoring services. LifeWatch services cater  to  individuals,   ranging from high-risk  and  chronically  ill  patients,  to   consumers  of  health  and wellness  products.  LifeWatch  has   subsidiaries  in  the  United  States,  the Netherlands, Japan, the United Kingdom, Switzerland and Israel. LifeWatch AG  is the parent company of  LifeWatch  Services  Inc.,  a  leading  US-based  cardiac monitoring service provider. LifeWatch has also introduced  a  new   program  for Home Sleep Testing of Obstructive Sleep Apnea (OSA)   patients  under  the  brand name NiteWatch. For additional information, please visit www.lifewatch.com.

About Aetna Aetna  is  one  of  the  nation´s  leading  diversified   health  care    benefits companies, serving  approximately  35.8   million  people  with  information  and resources to help them make better informed decisions about their health  care.  Aetna  offers  a broad  range  of  traditional  and  consumer-directed    health insurance products and related services, including  medical,   pharmacy,  dental, behavioral health, group life  and  disability   plans,  and  medical  management capabilities and  health  care   management  services  for  Medicaid  plans.  Our customers include employer groups, individuals, college students, part-time  and hourly workers, health plans, governmental  units,  government-sponsored   plans, labor groups and expatriates.  For more information, see www.aetna.com.

Sign-up for customized E-mail alerts and documentation requests is available  at http://production.investis.com/lifewatch/alert-service/

This press release includes forward-looking  statements.  All   statements  other than statements of historical facts contained in this press  release,  including statements regarding  future  results of  operations  and  financial  position, business strategy and plans and objectives for future operations,  are  forward- looking statements. The words "believe," "may," "will," "estimate,"   "continue," "anticipate,"  "intend,"  "expect"  and  similar   expressions  are  intended  to identify forward-looking statements.   LifeWatch  AG  has  based  these  forward- looking statements largely on current expectations and projections about  future events  and   financial  trends  that  it  believes  may  affect  the    financial condition, results of operations, business strategy, short term  and long  term business operations and objectives, and financial needs.   These  forward-looking statements are subject to a number of risks, uncertainties and  assumptions.  In light of these risks, uncertainties and assumptions, the forward-looking  events and circumstances described may  not  occur  and  actual  results  could differ materially and adversely from those  anticipated  or  implied in  the  forward- looking statements. All  forward-looking   statements  are  based  only  on  data available to LifeWatch AG at the time  of  the  issue  of  this  press  release. LifeWatch AG does not undertake any obligation  to  update  any  forward-looking statements contained in this press release  as  a  result  of  new   information, future events or otherwise.

THIS PRESS RELEASE IS NOT BEING ISSUED IN  THE  UNITED  STATES  OF   AMERICA  AND SHOULD NOT BE DISTRIBUTED TO  UNITED  STATES  PERSONS   OR  PUBLICATIONS  WITH  A GENERAL  CIRCULATION  IN  THE  UNITED   STATES.    THIS  PRESS  RELEASE  DOES  NOT CONSTITUTE AN OFFER OF SECURITIES OF LIFEWATCH AG OR  ANY  OF  ITS  SUBSIDIARIES FOR SALE IN THE UNITED STATES OR AN INVITATION TO SUBSCRIBE FOR OR PURCHASE  ANY SECURITIES OF LIFEWATCH  AG  OR  ITS  SUBSIDIARIES  IN  THE  UNITED   STATES.  IN ADDITION, THE SECURITIES OF LIFEWATCH AG AND  ITS   SUBSIDIARIES  HAVE  NOT  BEEN REGISTERED UNDER THE UNITED STATES SECURITIES LAWS AND MAY NOT BE OFFERED,  SOLD OR DELIVERED WITHIN THE UNITED STATES OR TO  U.S.  PERSONS  ABSENT  REGISTRATION UNDER OR AN APPLICABLE EXEMPTION  FROM  THE  REGISTRATION  REQUIREMENTS  OF  THE UNITED STATES SECURITIES LAWS.  ANY PUBLIC OFFERING OF SECURITIES TO BE MADE  IN THE UNITED STATES WILL BE MADE BY MEANS OF A PROSPECTUS   THAT  MAY  BE  OBTAINED FROM LIFEWATCH AG OR ITS SUBSIDIARIES, AS APPLICABLE, AND WILL CONTAIN  DETAILED INFORMATION ABOUT THE ISSUER AND ITS MANAGEMENT AS WELL AS FINANCIAL  STATEMENTS OF THE ISSUER.

@@start.t2@@end of announcement                                                 euro adhoc
--------------------------------------------------------------------------------@@end@@

ots Originaltext: LifeWatch AG
Im Internet recherchierbar: http://www.presseportal.ch

Further inquiry note:
For further information please contact:
Woo Kim, Senior Vice President of Strategy and Business Development, LifeWatch
Tel +1 847 813 4299 | Fax +1 847 813 24 48 | E-mail wkim@lifewatch.com

Sensus Investor & Public Relations, Zürich:
Tel +41 43 366 55 11 | Fax +41 43 366 55 12 | E-mail lifewatch@sensus.ch

Branche: Healthcare Providers
ISIN:      CH0012815459
WKN:        1281545
Index:    SPI, SPIEX
Börsen:  Frankfurt / Open Market / XETRA
              Berlin / free trade
              SIX Swiss Exchange / Main Standard



Weitere Meldungen: LifeWatch AG

Das könnte Sie auch interessieren: